172 related articles for article (PubMed ID: 24491425)
21. Extranodal hematopoietic/lymphoid disorders. An introduction.
Burke JS
Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S40-5. PubMed ID: 9894468
[TBL] [Abstract][Full Text] [Related]
22. Expression of the RET receptor tyrosine kinase and GDNFR-alpha in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment.
Gattei V; Celetti A; Cerrato A; Degan M; De Iuliis A; Rossi FM; Chiappetta G; Consales C; Improta S; Zagonel V; Aldinucci D; Agosti V; Santoro M; Vecchio G; Pinto A; Grieco M
Blood; 1997 Apr; 89(8):2925-37. PubMed ID: 9108413
[TBL] [Abstract][Full Text] [Related]
23. Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes.
Witkowski M; Witkowski M; Saffarzadeh M; Friebel J; Tabaraie T; Ta Bao L; Chakraborty A; Dörner A; Stratmann B; Tschoepe D; Winter SJ; Krueger A; Ruf W; Landmesser U; Rauch U
Cardiovasc Diabetol; 2020 Feb; 19(1):20. PubMed ID: 32066445
[TBL] [Abstract][Full Text] [Related]
24. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of CD54/intercellular adhesion molecule-1 in myeloid leukemias and in lymphoproliferative disorders.
Maio M; Pinto A; Carbone A; Zagonel V; Gloghini A; Marotta G; Cirillo D; Colombatti A; Ferrara F; Del Vecchio L
Blood; 1990 Aug; 76(4):783-90. PubMed ID: 1974471
[TBL] [Abstract][Full Text] [Related]
26. Tissue Factor: An Essential Mediator of Hemostasis and Trigger of Thrombosis.
Grover SP; Mackman N
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):709-725. PubMed ID: 29437578
[TBL] [Abstract][Full Text] [Related]
27. Cancer and thrombosis in women - molecular mechanisms.
Rickles FR
Thromb Res; 2009; 123 Suppl 2():S16-20. PubMed ID: 19217469
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma.
Medeiros LJ; Picker LJ; Abel EA; Hu CH; Hoppe RT; Warnke RA; Wood GS
J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):929-42. PubMed ID: 2808829
[TBL] [Abstract][Full Text] [Related]
29. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.
Stein H; Mason DY; Gerdes J; O'Connor N; Wainscoat J; Pallesen G; Gatter K; Falini B; Delsol G; Lemke H
Blood; 1985 Oct; 66(4):848-58. PubMed ID: 3876124
[TBL] [Abstract][Full Text] [Related]
30. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
[TBL] [Abstract][Full Text] [Related]
31. Myeloid, B and T lymphoid and mixed lineage thymic lymphomas in the irradiated mouse.
Boulton E; Cleary H; Plumb M
Carcinogenesis; 2002 Jun; 23(6):1079-85. PubMed ID: 12082032
[TBL] [Abstract][Full Text] [Related]
32. Hypercoagulability in patients with haematological neoplasia: no apparent initiation by tissue factor.
Negaard HF; Iversen PO; Østenstad B; Iversen N; Holme PA; Sandset PM
Thromb Haemost; 2008 Jun; 99(6):1040-8. PubMed ID: 18521506
[TBL] [Abstract][Full Text] [Related]
33. Notch-ing from T-cell to B-cell lymphoid malignancies.
Mirandola L; Comi P; Cobos E; Kast WM; Chiriva-Internati M; Chiaramonte R
Cancer Lett; 2011 Sep; 308(1):1-13. PubMed ID: 21652011
[TBL] [Abstract][Full Text] [Related]
34. Expression of activation-induced cytidine deaminase in malignant lymphomas infiltrating the bone marrow.
Engels K; Jungnickel B; Tobollik S; Hansmann ML; Kriener S; Willenbrock K
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):521-9. PubMed ID: 18776814
[TBL] [Abstract][Full Text] [Related]
35. Tissue factor expression and angiogenesis in human glioma.
Guan M; Jin J; Su B; Liu WW; Lu Y
Clin Biochem; 2002 Jun; 35(4):321-5. PubMed ID: 12135696
[TBL] [Abstract][Full Text] [Related]
36. Role of tissue factor in hemostasis, thrombosis, and vascular development.
Mackman N
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1015-22. PubMed ID: 15117736
[TBL] [Abstract][Full Text] [Related]
37. Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model.
Hobbs JE; Zakarija A; Cundiff DL; Doll JA; Hymen E; Cornwell M; Crawford SE; Liu N; Signaevsky M; Soff GA
Thromb Res; 2007; 120 Suppl 2():S13-21. PubMed ID: 18023707
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling identifies IRF4-associated molecular signatures in hematological malignancies.
Wang L; Yao ZQ; Moorman JP; Xu Y; Ning S
PLoS One; 2014; 9(9):e106788. PubMed ID: 25207815
[TBL] [Abstract][Full Text] [Related]
39. Regulated genomic instability and neoplasia in the lymphoid lineage.
Vanasse GJ; Concannon P; Willerford DM
Blood; 1999 Dec; 94(12):3997-4010. PubMed ID: 10590043
[No Abstract] [Full Text] [Related]
40. Interleukin-13 gene expression by malignant and EBV-transformed human B lymphocytes.
Fior R; Vita N; Raphael M; Minty A; Maillot MC; Crevon MC; Caput D; Biberfeld P; Ferrara P; Galanaud P
Eur Cytokine Netw; 1994; 5(6):593-600. PubMed ID: 7727691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
